Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    12538745 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Phase II Study on Gusperimus in Patients With Refractory Wegener's Granulomatosis
Condition: Wegener's Granulomatosis
Intervention: Drug: Gusperimus

Indicates status has not been verified in more than two years